当前位置: 首页 > 详情页

The expression and function of Frizzled-7 in human renal cell carcinoma

文献详情

资源类型:

收录情况: ◇ SCIE

机构: [1]Department of Pharmacy, College of Pharmaceutical Science, Soochow University, Suzhou 215123, China [2]Department of Immunology, School of Basic Medicine and Life Sciences, Medical College, Soochow University, Suzhou, China [3]The Department of Urology, The Second Affiliated Hospital of Soochow University, Suzhou, China
出处:
ISSN:

关键词: Frizzled 7 (Fzd7) Renal cell carcinoma (RCC) Wnt3a Cell proliferation

摘要:
Wnt/beta-catenin has emerged as an important signal pathway in renal cell carcinoma (RCC) pathogenesis. Frizzled 7 (Fzd7) is a member of Frizzled (Fzd) receptor family which binds with Wnt ligands and transduces canonical and non-canonical pathways. However, the expression of Fzd7 in human RCC is poorly investigated. 53 RCC tissues and peri-tumor tissues were collected from the patients treated with radical nephrectomy. The expression of Fzd7 was investigated by immunohistochemical staining. Three RCC cells were transfected with Fzd7shRNA and GFPshRNA to investigate the function of Fzd7 in RCC cells. The immunohistochemical analysis showed that Fzd7 protein expression level was significantly increased in RCC tissues when compared with peri-tumor tissues, which suggested that Fzd7 might be involved in the formation of tumors. However, the Fzd7 expression was not correlated with clinicopathological parameters. Three RCC cell lines: 786-O, Caki-1, and OS-RC-2 also expressed Fzd7. With Fzd7 expression being interfered by shRNA, the RCC cell proliferation was mildly decreased. Wnt3a could stimulate the RCC cells proliferation, but the stimulation was decreased when Fzd7 expression was interfered. Restoring the Fzd7 expression led to the proliferation stimulation effect of Wnt3a being restored. This paper suggests that Fzd7 may act as one of the molecules that take part in the course of RCC formation. Fzd7 can be activated by Wnt3a to stimulate cell proliferation.

基金:
语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2015]版:
大类 | 4 区 医学
小类 | 4 区 肿瘤学
最新[2025]版:
大类 | 4 区 医学
小类 | 4 区 肿瘤学
JCR分区:
出版当年[2014]版:
Q3 ONCOLOGY
最新[2023]版:
Q2 ONCOLOGY

影响因子: 最新[2023版] 最新五年平均 出版当年[2014版] 出版当年五年平均 出版前一年[2013版] 出版后一年[2015版]

第一作者:
第一作者机构: [1]Department of Pharmacy, College of Pharmaceutical Science, Soochow University, Suzhou 215123, China
通讯作者:
通讯机构: [1]Department of Pharmacy, College of Pharmaceutical Science, Soochow University, Suzhou 215123, China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:17095 今日访问量:1 总访问量:921 更新日期:2025-04-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 首都医科大学宣武医院 技术支持:重庆聚合科技有限公司 地址:北京市西城区长椿街45号宣武医院